Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs

Carcinogenesis

Volumn 28, Issue 4, 2007, Pages 777-784

  Tambe, Yukihiro ^a   Yoshioka Yamashita, Atsuko ^a,g   Mukaisho, Ken Ichi ^a   Haraguchi, Seiki ^a,h   Chano, Tokuhiro ^a   Isono, Takahiro ^a   Kawai, Takao ^b   Suzuki, Yasuhiko ^c   Kushima, Ryoji ^a   Hattori, Takanori ^a   Goto, Motohito ^d   Yamada, Shuichi ^e   Kiso, Makoto ^f   Saga, Yumiko ^f   Inoue, Hirokazu ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d SPOC Inc   (Japan)

^e AKITA UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF GENETICS   (Japan)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 12; CASPASE 3; CASPASE 9;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; GENE FUNCTION; KNOCKOUT MOUSE; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WILD TYPE;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CASPASES; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EMBRYO; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY; LUNG NEOPLASMS; LYMPHOMA; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; PHENOTYPE; RECOMBINATION, GENETIC; RNA, MESSENGER; TRANSFECTION;

EID: 34047108229     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl211     Document Type: Article

References (41)

1. Hollstein,M., Sidransky,D., Vogelstein,B and Harris,C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
2. Tsujimoto,Y., Finger,L.R., Yunis,J., Nowell,P.C. and Croce,C.M. (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science, 226, 1097-1099.
3. Bellacosa,A., Testa,J.R., Staal,S.P. and Tsichlis,P.N. (1991) A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science, 254, 274-277.
4. Altomare,D.A. and Testa,J.R. (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene, 24, 7455-7464.
5. Pan,J., Nakanishi,K., Yutsudo,M., Inoue,H., Li,Q., Oka,K., Yoshioka,N. and Hakura,A. (1996) Isolation of a novel gene down-rgulated by v-src. FEBS Lett., 383, 21-25.
6. Inoue,H., Pan,J. and Hakura,A. (1998) Suppression of v-Src transformation by the drs gene. J. Virol., 72, 2532-2537.
7. Norman,D.G., Barlow,P.N., Baron,M., Day,A.J., Sim,R.B. and Campbell,I.D. (1991) Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol., 219, 717-725.
8. Lasky,L.A. (1992) Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science, 258, 964-969.
9. Kansas,G.S. (1996) Selectins and their ligands: Current concepts and controversies. Blood, 88, 3259-3287.
10. Rubinfeld,B., Robbins,P., El-Gamil,M., Albert,I., Porfiri,E. and Polakis,P. (1997) Structure-function relationships of the complement components. Science, 275, 1790-1792.
11. Bommer,G.T., Jäger,C., Dürr,E. et al. (2005) DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells. J. Biol. Chem., 280, 7962-7975.
12. Yamashita,A., Hakura,A. and Inoue,H. (1999) Suppression of anchorage-independent growth of human cancer cell lines by the drs gene. Oncogene, 18, 4777-4787.
13. Shimakage,M., Kawahara,K., Kikkawa,N., Sasagawa,T., Yutsudo,M. and Inoue,H. (2000) Downregulation of drs mRNA in human colon adenocarcinomas. Int. J. Cancer, 87, 5-11.
14. Mukaisho,K., Suo,M., Shimakage,M., Kushima,R., Inoue,H. and Hattori,T. (2002) Down-regulation of drs mRNA in colorectal neoplasms. Jpn. J. Cancer Res., 93, 888-893.
15. Shimakage,M., Takami,K., Kodama,K., Mano,M., Yutsudo,M. and Inoue,H. (2002) Expression of drs mRNA in human lung adenocarcinomas. Hum. Pathol., 33, 615-619.
16. Kim,C.J., Shimakage,M., Kushima,R., Mukaisho,K., Shinka,T., Okada,Y. and Inoue,H. (2003) Down-regulation of drs mRNA in human prostate carcinomas. Hum. Pathol., 34, 654-657.
17. Tambe,Y., Isono,T., Haraguchi,S., Yoshioka-Yamashita,A., Yutsudo,M. and Inoue,H. (2004) A novel apoptotic pathway induced by the drs tumor suppressor gene. Oncogene, 23, 2977-2987.
18. Li,Q., Qi,B., Oka,K., Shimakage,M., Yoshioka,N., Inoue,H., Hakura,A., Kodama,K., Stanbridge,E.J. and Yutsudo,M. (2001) Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene, 20, 3929-3936.
19. Chen,M.S., Huber,A.B., van der Haar,M.E., Frank,M., Schnell,L., Spillmann,A.A., Christ,F. and Schwab,M.E. (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature, 403, 434-439.
20. L and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene, 19, 5736-5746.
21. Nagy,A., Rossant,J., Nagy,R., Abramow-Newerly,W. and Roder,J.C. (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA, 90, 8424-8428.
22. Sakai,K. and Miyazaki,J. (1997) A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem. Biophys. Res. Commun., 237, 318-324.
23. Kawai,T., Suzuki,Y., Yamashita,A. and Inoue,H. (2002) Isolation of a novel mouse variant of the drs tumor suppressor gene. Cancer Lett., 183, 79-86.
24. Akagi,Y., Shishido,T., Murata,K. and Hanafusa,H. (2000) v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc. Natl Acad. Sci. USA, 97, 7290-7295.
25. Naviaux,R.K., Costanzi,E., Haas,M. and Verma,I.M. (1996) The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol., 70, 5701-5705.
26. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
27. Shen,Y. and White,E. (2001) p53-dependent apoptosis pathways. Adv. Cancer Res., 82, 55-84.
28. Donehower,L.A., Harvey,M., Slagle,B.L., McArthur,M.J., Montgomery,C.A.,Jr, Butel,J.S. and Bradley,A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 356, 215-221.
29. Lowe,S.W., Schmitt,E.M., Smith,S.W., Osborne,B.A. and Jacks,T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
30. Clarke,A.R., Purdie,C.A., Harrison,D.J., Morris,R.G., Bird,C.C., Hopper,M.L. and Wyllie,H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
31. Tsukada,T., Tomooka,Y., Takai,S. et al. (1993) Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene, 8, 3313-3322.
32. Purdie,C.A., Harrison,D.J., Peter,A. et al. (1994) Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene, 9, 603-609.
33. Jacks,T., Remington,L., Williams,B.O., Schmitt,E.M., Halachmi,S., Bronson,R.T. and Weinberg,R.A. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
34. Levine,A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
35. Efeyan,A., Garcia-Cao,I., Herranz,D., Velasco-Miguel,S. and Serrano,M. (2006) Tumour biology: Policing of oncogene activity by p53. Nature, 443, 159.
36. Christophorou,M.A., Ringshausen,I., Finch,A.J., Swigart,L.B. and Evan,G.I. (2006) The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature, 443, 214-217.
37. Hacki,J., Egger,L., Monney,L., Conus,S., Rosse,T., Fellay,I. and Borner,C. (2000) Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene, 19, 2286-2295.
38. Annis,M.G., Zamzami,N., Zhu,W., Penn,L.Z., Kroemer,G., Leber,B. and Andrews,D.W. (2001) Endoplasmic reticulum localized Bcl-2 prevents apoptosis when redistribution of cytochrome c is a late event. Oncogene, 20, 1939-1952.
39. Rudner,J., Lepple-Wienhues,A., Budach,W., Berschauer,J., Friedrich,B., Wesselborg,S., Schulze-Osthoff,K. and Belka,C. (2001) Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J. Cell Sci., 114, 4161-4172.
40. Ferri,K.F. and Kroemer,G. (2001) Organelle-specific initiation of cell death pathways. Nat. Cell Biol., 3, E255-E263.
41. 2+: A control point for apoptosis. Science, 300, 135-139.